Specifically, while knockdown of BSG/CD147 or treatment with DPP4 inhibitor (vildagliptin) significantly reduces SARS-CoV-2 infection, conversely overexpressing BSG/CD147 or DPP4 increases infection in vitro. The gene discussed is BSG; the disease is infection.